PAPERS - RESEARCH FRONT: 11
| TITLE | 1ST AUTHOR | YEAR |
| PLAYING CLUE WITH PRION DISEASE |
ROBERTS GW |
1991 |
| ATTEMPTS TO CONVERT THE CELLULAR PRION PROTEIN INTO THE SCRAPIE ISOFORM IN CELL-FREE SYSTEMS |
RAEBER AJ |
1992 |
| PRION DISEASE - THE ESSENTIAL FACTS |
CLINTON J |
1992 |
| 3 SCRAPIE PRION ISOLATES EXHIBIT DIFFERENT ACCUMULATION PATTERNS OF THE PRION PROTEIN SCRAPIE ISOFORM |
DEARMOND SJ |
1993 |
| ALZHEIMERS-DISEASE AND CREUTZFELDT-JAKOB-DISEASE - OVERLAP OF PATHOGENIC MECHANISMS |
DEARMOND SJ |
1993 |
| VERTICAL TRANSFER OF PRION DISEASE |
LACEY RW |
1994 |
| SPONGIFORM ENCEPHALOPATHIES AND PRIONS - AN OVERVIEW OF PATHOLOGY AND DISEASE MECHANISMS |
FAIRBAIRN DW |
1994 |
| DOUBLE REPLACEMENT GENE TARGETING FOR THE PRODUCTION OF A SERIES OF MOUSE STRAINS WITH DIFFERENT PRION PROTEIN GENE ALTERATIONS |
MOORE RC |
1995 |
| PRION PROPAGATION IN MICE EXPRESSING HUMAN AND CHIMERIC PRP TRANSGENES IMPLICATES THE INTERACTION OF CELLULAR PRP WITH ANOTHER PROTEIN |
TELLING GC |
1995 |
| What went wrong in BSE? From prion disease to public disaster |
Baker HF |
1996 |
| Normal host prion protein necessary for scrapie-induced neurotoxicity |
Brandner S |
1996 |
| Human transmissible subacute spongiform encephalopathies. |
Dormont D |
1996 |
| A new variant of prion disease |
Collinge J |
1996 |
| Interactions between wild-type and mutant prion proteins modulate neurodegeneration transgenic mice |
Telling GC |
1996 |
| To what extent is strain variation evidence for an independent genome in the agent of the transmissible spongiform encephalopathies? |
Ridley RM |
1996 |
| Variation on a theme of Creutzfeldt-Jakob disease: Implications of new cases with a young age at onset |
Ridley RM |
1996 |
| Genetics of prions |
Prusiner SB |
1997 |
| A novel hamster prion protein mRNA contains an extra exon: Increased expression in scrapie |
Li G |
1997 |
| Deadly conformations - Protein misfolding in prion disease |
Horwich AL |
1997 |
| Transgenic analysis of prion diseases |
Moore RC |
1997 |
| Selective neuronal targeting in prion disease |
DeArmond SJ |
1997 |
| A transmembrane form of the prion protein in neurodegenerative disease |
Hegde RS |
1998 |
| The paradoxical dynamics of prion disease latency |
Payne RJH |
1998 |
| Prions and the prion disorders |
Fisher E |
1998 |
| Prion's progress: Patterns and rates of molecular evolution in relation to spongiform disease |
Krakauer DC |
1998 |
| Doxycycline control of prion protein transgene expression modulates prion disease in mice |
Tremblay P |
1998 |
| The spatial dynamics of prion disease |
Payne RJH |
1998 |
| Current status of bovine spongiform encephalopathy - A review |
Brewer MS |
1999 |
| Is the pathogen of prion disease a microbial protein? |
Fuzi M |
1999 |
| Transgenic models for prion disease: Have they outlived their useful purpose? |
Jenkins ES |
1999 |
| The welfare problems associated with using transgenic mice to bioassay for bovine spongiform encephalopathy |
Jenkins ES |
1999 |
| A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy |
Manson JC |
1999 |
| Transmissible and genetic prion diseases share a common pathway of neurodegeneration |
Hegde RS |
1999 |
| A transgenic model of a familial prion disease |
Harris DA |
2000 |
| Transgenic models of prion disease |
Scott MR |
2000 |
| Lack of evidence to support the association of the human prion gene with schizophrenia |
Tsai MT |
2001 |
| Transmissible spongiform encephalopathies or prion diseases. |
Dormont D |
2001 |
| Isolation and functional characterisation of the promoter region of the human prion protein gene |
Mahal SP |
2001 |
| Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody |
Enari M |
2001 |
| Huntington disease phenocopy is a familial prion disease |
Moore RC |
2001 |
| The transmissible spongiform encephalopathies (prion diseases): A review for dental surgeons |
Gill DS |
2001 |
| The animal and human prion diseases: Public health importance and risk assessment |
Vitale K |
2001 |
| Rapid detection of the prion protein M129V polymorphism with the LightCycler |
Teupser D |
2002 |
| PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease |
McCormack JE |
2002 |
| All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturation |
Rybner C |
2002 |
| Expression pattern of a mini human PrP gene promoter in transgenic mice |
Asante EA |
2002 |
| Mouse models of prion disease transmission |
Baron T |
2002 |
| Human prion diseases |
Thakur R |
2002 |
| Fundamentals of prion biology and diseases |
DeArmond SJ |
2002 |
| PrP knock-out and PrP transgenic mice in prion research |
Weissmann C |
2003 |
| Dental practice implications of prion diseases |
Bebermeyer RD |
2003 |
| Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment |
DeArmond SJ |
2003 |
| A murine model of a familial prion disease |
Harris DA |
2003 |
| Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics |
Mead S |
2003 |
| Post-transcriptional suppression of pathogenic prion protein expression in Drosophila neurons |
Deleault NR |
2003 |
| What would T. H. Huxley have made of prion diseases? |
Ridley RM |
2003 |
| Molecular distinction between pathogenic and infectious properties of the prion protein |
Chiesa R |
2003 |
| Mutant PrPSc conformers induced by a synthetic peptide and several prion strains |
Tremblay P |
2004 |
| The role of PrP in health and disease |
Flechsig E |
2004 |
| The public health impact of prion diseases |
Belay ED |
2005 |
| Prion disease: A deadly disease for protein misfolding |
Chakraborty C |
2005 |
| Human and animal spongiform encephalopathies are the result of chronic autolmmune attack in the CNS: A novel medical theory supported by overwhelming experimental evidence |
Zhu BT |
2005 |